Syngenta is committed to developing innovative solutions for vector disease control
Syngenta invests $1.3 billion per year on R&D and work together with non-profit organizations to develop formulations that help to fight disease-carrying agents such as dengue fever, malaria, chikungunya fever, and filariasis.
We believe people around the world should live their lives uninterrupted by insects and vector-borne diseases like dengue fever and malaria. Mosquitoes are the primary cause of malaria, which affects hundreds of thousands of people each year. With Syngenta mosquito vector control solutions, these pests can be controlled to prevent harmful diseases and make a positive difference in the lives of people around the world.
For more than a decade, Syngenta has been committed to protecting people and working towards dengue and malaria eradication, by partnering with non-profit organizations such as IVCC (Innovative Vector Control Consortium) and others.